Inventor
CAI ZELING
CN25 patents
⚠️ This page may combine multiple inventors who share the name “CAI ZELING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CAI ZELING
11 patentsUS8084256B2Dec 27, 2011
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
CAI ZELING10 citations91
US8124408B2Feb 28, 2012
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
CAI ZELING15 citations89
US8232101B2Jul 31, 2012
Identification of antigenic peptides from multiple myeloma cells
CAI ZELING2 citations59
US8075895B2Dec 13, 2011
Identification of antigenic peptides from multiple myeloma cells
CAI ZELING1 citations59
US8133726B2Mar 13, 2012
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
CAI ZELING0 citations51
US8133972B2Mar 13, 2012
IgE antigenic peptides
CAI ZELING0 citations51
US8133728B2Mar 13, 2012
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
CAI ZELING0 citations51
US8106153B2Jan 31, 2012
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
CAI ZELING0 citations51
US8084253B2Dec 27, 2011
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
CAI ZELING0 citations51
US8323655B2Dec 4, 2012
Identification of antigenic peptides from multiple myeloma cells
CAI ZELING0 citations49
US8323965B2Dec 4, 2012
Identification of antigenic peptides from multiple myeloma cells
CAI ZELING0 citations49
SCRIPPS RESEARCH INST
6 patentsUS6362001B1Mar 26, 2002
Method for producing a synthetic antigen presenting transformed Drosophila cell
SCRIPPS RESEARCH INST45 citations95
US6255073B1Jul 3, 2001
Antigen presenting system and methods for activation of T-cells
SCRIPPS RESEARCH INST79 citations95
US6225042B1May 1, 2001
Antigen presenting system and methods for activation of T-cells
SCRIPPS RESEARCH INST55 citations95
US6461867B1Oct 8, 2002
Synthetic antigen presenting matrix
SCRIPPS RESEARCH INST22 citations91
US6828150B2Dec 7, 2004
Antigen presenting system and methods for activation of T-cells
SCRIPPS RESEARCH INST11 citations80
US6251627B1Jun 26, 2001
Antigen presenting system and methods for activation of T-cells
SCRIPPS RESEARCH INST5 citations73
SHANGHAI KANDA BIOTECHNOLOGY CO LTD
3 patentsUS10562954B2Feb 18, 2020
Fusion protein inhibiting TACI-BAFF complex formation and preparation method therefor and use thereof
SHANGHAI KANDA BIOTECHNOLOGY CO LTD3 citations66
US11208483B2Dec 28, 2021
CTLA-4 antibodies and uses thereof
SHANGHAI KANDA BIOTECHNOLOGY CO LTD0 citations60
US11021538B2Jun 1, 2021
Bispecific coupled antibody, preparation method and application thereof
SHANGHAI KANDA BIOTECHNOLOGY CO LTD1 citations60